ES532018A0 - Un dispositivo para liberar a una velocidad controlada un agente beneficioso a un medio de uso - Google Patents

Un dispositivo para liberar a una velocidad controlada un agente beneficioso a un medio de uso

Info

Publication number
ES532018A0
ES532018A0 ES532018A ES532018A ES532018A0 ES 532018 A0 ES532018 A0 ES 532018A0 ES 532018 A ES532018 A ES 532018A ES 532018 A ES532018 A ES 532018A ES 532018 A0 ES532018 A0 ES 532018A0
Authority
ES
Spain
Prior art keywords
release
medium
beneficial agent
controlled speed
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES532018A
Other languages
English (en)
Spanish (es)
Other versions
ES8503503A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES532018(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of ES8503503A1 publication Critical patent/ES8503503A1/es
Publication of ES532018A0 publication Critical patent/ES532018A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
ES532018A 1983-05-11 1984-04-27 Un dispositivo para liberar a una velocidad controlada un agente beneficioso a un medio de uso Granted ES532018A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11

Publications (2)

Publication Number Publication Date
ES8503503A1 ES8503503A1 (es) 1985-03-01
ES532018A0 true ES532018A0 (es) 1985-03-01

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
ES532018A Granted ES532018A0 (es) 1983-05-11 1984-04-27 Un dispositivo para liberar a una velocidad controlada un agente beneficioso a un medio de uso

Country Status (20)

Country Link
JP (1) JPS6041609A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT397180B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU566110B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE898819A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1222950A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH669329A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3417113A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK163910C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES532018A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2545721B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2140687B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE56515B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL71727A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1178911B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX163518B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL192250C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO170834C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ206600A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE455918B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA842422B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
ES8800043A1 (es) * 1985-08-16 1987-10-16 Alza Corp Un dispositivo distribuidor para descargar una formulacion de agente beneficioso a un entorno de uso
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
EP0317780B1 (en) * 1987-11-25 1992-05-20 American Cyanamid Company Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
CA2087435C (en) * 1990-08-07 1998-05-05 Scott Max Herbig Use of interfacially-polymerized membranes in delivery devices
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
ATE106015T1 (de) * 1990-09-28 1994-06-15 Pfizer Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält.
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
DE69426997T2 (de) * 1993-02-23 2001-11-15 Heikki Sirkkola Die Verwendung eines Calciumpräparates in einem Medikament zur Behandlung von an Hypocalcämie leidenden Milchkühen
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
JP2004512354A (ja) * 2000-10-30 2004-04-22 ユーロ−セルティーク，エス．エイ． ヒドロコドン放出制御製剤
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
KR101164881B1 (ko) 2003-09-19 2012-07-23 썬 파마슈티컬 인더스트리스 리미티드 경구용 약물 전달 시스템
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005031577A1 (de) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
ATE502937T1 (de) 2005-10-04 2011-04-15 Bayer Schering Pharma Ag Neue polymorphe form von 5-chlor-n-(ä ( 5s )-2- 0x0-3-ä4-( 3-oxo-4-morpholinyl)-phenylü-1,3- oxazolidin-5-ylü -methyl)-2-thiophencarboxamid
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
WO2010139111A1 (en) * 2009-06-02 2010-12-09 Dow Global Technologies Inc. Sustained release dosage form
DE102011007272A1 (de) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
WO2013167453A1 (en) 2012-05-07 2013-11-14 Bayer Pharma Aktiengesellschaft Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
UY34856A (es) 2012-07-03 2013-12-31 Bayer Pharma AG Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form
CA3107169A1 (en) 2018-07-24 2020-01-30 Bayer Aktiengesellschaft Pharmaceutical dosage form which can be administered orally and has modified release
WO2020020790A1 (de) 2018-07-24 2020-01-30 Bayer Aktiengesellschaft Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38538A (en) * 1971-01-13 1974-09-10 Alza Corp Osmotic dispenser
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Also Published As

Publication number Publication date
ES8503503A1 (es) 1985-03-01
JPS6041609A (ja) 1985-03-05
BE898819A (fr) 1984-05-30
JPH0575725B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-10-21
DE3417113A1 (de) 1984-11-15
NL8401470A (nl) 1984-12-03
NO170834B (no) 1992-09-07
FR2545721B1 (fr) 1987-11-06
DE3417113C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-02-02
AT397180B (de) 1994-02-25
GB2140687A (en) 1984-12-05
GB2140687B (en) 1987-03-18
SE455918B (sv) 1988-08-22
GB8334189D0 (en) 1984-02-01
NL192250C (nl) 1997-04-03
IT8467283A1 (it) 1985-09-23
IE840010L (en) 1984-11-11
MX163518B (es) 1992-05-25
AU566110B2 (en) 1987-10-08
SE8402512L (sv) 1984-11-12
DK99784A (da) 1984-11-12
NO840248L (no) 1984-11-12
NL192250B (nl) 1996-12-02
DK99784D0 (da) 1984-02-24
DK163910C (da) 1992-09-14
AU2251183A (en) 1984-11-15
NZ206600A (en) 1987-01-23
FR2545721A1 (fr) 1984-11-16
IL71727A (en) 1989-01-31
ZA842422B (en) 1984-11-28
CH669329A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-03-15
IL71727A0 (en) 1984-09-30
IT8467283A0 (it) 1984-03-23
IT1178911B (it) 1987-09-16
SE8402512D0 (sv) 1984-05-09
IE56515B1 (en) 1991-08-28
DK163910B (da) 1992-04-21
NO170834C (no) 1992-12-16
ATA88084A (de) 1993-07-15
CA1222950A (en) 1987-06-16

Similar Documents

Publication Publication Date Title
ES532018A0 (es) Un dispositivo para liberar a una velocidad controlada un agente beneficioso a un medio de uso
AR240398A1 (es) Dispositivo para administrar un agente beneficial a un animal
AR229354A1 (es) Procedimiento para preparar una formulacion estabilizada de ivermectina en agua
AR222148A1 (es) Una composicion para usar en la formacion de elementos de friccion
ES556303A0 (es) Un dispositivo distribuidor para descargar una formulacion de agente beneficioso a un entorno de uso
BR8303523A (pt) Absorvente sanitario
DK113779A (da) Absorberende engangspude
ES500779A0 (es) Un metodo para preparar una composicion de colorante liquiday acuosa
FR2416006B1 (fr) Serviette absorbante pour exsudats
ES503119A0 (es) Procedimiento y dispositivo para la eliminacion de agua so- brante de una mezcla de yeso y agua
MX160591A (es) Procedimiento para preparar una solucion estable de xatano
ES526831A0 (es) Procedimiento para preparar una dispersion diluible en agua de particulas polimericas
ES538602A0 (es) Prefeccionamiento introducidos en un aparato para cerrar termicamente un segmento seleccionado de una banda
MX158039A (es) Mejoras en panal contra la incontinencia
FR2522374B1 (fr) Butee de debrayage hydraulique
ES556572A0 (es) Un dispositivo distribuidor para descargar una formulacion de agente beneficioso a un entorno de uso
ES537051A0 (es) Procedimiento para preparar una composicion de organopolisiloxano
ES492908A0 (es) Perfeccionamientos en dispositivos para limpiar los chaponescirculatorios de una cerda
ES296272Y (es) Dispositivo para bloquear una tuberia
ES284622Y (es) Dispositivo para preparar y suministrar una solucion.
ES538104A0 (es) Un sistema osmotico para la descarga de un agente beneficioso a un medio de uso
DK159991C (da) Arbejdsstol med svingbart ryglaen
DK541783A (da) Antimykotisk middel i form af et gelsystem med kraftig frigoerelse af aktivt stof
LU80953A1 (fr) Nouvelle structure absorbante perfectionnee
ES528240A0 (es) Perfeccionamientos en dispositivos para mejorar la seguridad de limitadores de velocidad